Recent Headlines
Within Pharmaceuticals
Advanced Orthopedics and Sports Medicine Institute of Freehold, NJ, Moves Wall Township Office to Lake Como
AOSMI (Advanced Orthopedics and Sports Medicine Institute), of Freehold, NJ, has moved its Wall Township office to 1719 Main Street, Lake Como, in order to expand services for patients. - May 04, 2012 - Advanced Orthopedics and Sports Medicine Institute, PC
MedPro Rx, Inc. Named One of 50 Fastest-Growing Women-Owned Companies in North America
Specialty Pharmacy Owned by City of Raleigh, N.C. Mayor Nancy McFarlane, Recognized by American Express OPEN And Women Presidents’ Organization (WPO) - May 04, 2012 - MedPro Rx, Inc.
Dr. Glenn Atlas, Stevens Students, and MICRO Stamping Corp. Develop Innovative Medical Technology
V-Scope is a new medical device to help doctors position a breathing tube - May 03, 2012 - Stevens Institute of Technology
Mitutoyo America Corporation Opens Alabama M3 Solution Center
The opening of the Birmingham, AL. showroom benefits customers in the south central region. - May 02, 2012 - Mitutoyo America Corporation
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite
State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
pharmaCline's Diabecline antibiotic ointment has been recognized as the Bronze Award winner for Best New Pharmaceutical Product by the Edison Awards. - May 01, 2012 - pharmaCline
Ameridose Supports Pharmacy Leadership Forum
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is honored to sponsor the Executive Forum segment of Boston University School of Management’s 2012 Pharmacy Leadership Institute program. This year’s Executive Forum is titled... - May 01, 2012 - Ameridose, LLC
Opti Sleep Releases Insomnia Trial Data
Opti Sleep, the new clinically proven treatment for sleep problems, has released details of its latest clinical study to treat insomnia and those suffering from interrupted sleep, showing improved sleep response in over 90% of participants. - April 30, 2012 - Opti Sleep
Stroke Does Not Discriminate – Prevention Through Technology and Risk Modification Crucial to Stopping Stroke from Striking
Stroke does not discriminate; it can strike anyone, anytime, anywhere, with 795,000 stroke cases a year in the U.S. alone. Some risk factors are controllable, and if modified will result in a significant decrease in the incidence of stroke. The Stroke Shield Foundation is promoting the message Technology Against Stroke this May in recognition of National Stroke Awareness Month. - April 30, 2012 - Dr. Jeffrey Thomas Stroke Shield Foundation
ImmunoReagents Announces Exclusive German Distribution Channel with BioLeague
ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Bioleague as its new distributor in Germany. ImmunoReagents and Bioleague will work together to bring top quality antibodies to the... - April 29, 2012 - ImmunoReagents Inc.
Source-Omega Critical of IOM Alleged Handling of Historical Omega-3 Data
The Source-Omega company today raised criticism that “The Institute of Medicine has now allegedly been wrong three times with respect to the 41 years history of data on marine long-chain omega-3 fatty acid knowledge and associated claims made based on fundamental misinterpretations of the... - April 28, 2012 - Source-Omega
Med4Nicaragua Team Joins Medical Volunteer Program Abroad
A team of medical professionals with Med4Nicaragua traveled to the rural community of Limon in southwest Nicaragua to volunteer their time, expertise, and services to local patients of the Roberto Clemente Health Clinic. The group consisted of general surgeons, registered nurses,... - April 28, 2012 - The Roberto Clemente Health Clinic
New Research: HidroxⓇ Inhibits E. coli and Reduces Neuroinflammation
While nutraceuticals and dietary supplements are coming under increasing regulatory scrutiny, both in the United States and Europe, for what is perceived to be a lack of verifiable scientific research supporting their claim to beneficial health effects, CreagriⓇ Inc., and HidroxⓇ--its patented formulation of olive polyphenols rich in the potent antioxidant Hydroxytyrosol - continue to achieve new scientific advancements on the road to producing healthy consumer goods. - April 28, 2012 - Creagri, Inc.
Fertility Preservation Options for Cancer Patients Discussed at FSOSW Meeting
The Florida Society of Oncology Social Workers held its regional meeting on April 26, where the main focus was Fertility Preservation options for Cancer patients. This month’s program strives to promote education and extend access to fertility preservation services. - April 27, 2012 - ReproTech, LLC
Pharmaceutical Operations Provider, Inc. Announces Brent Galletta Has Joined Their Management Team as Vice President of Business Development
Pharmaceutical Operations Provider has brought Brent Galletta in as Vice President of Business Development to implement new sales and support strategies. These strategies include developing strong longstanding relationships with clients looking to provide their sales representatives with the most comprehensive PDMA compliant mobile sales CRM. - April 27, 2012 - Pharmaceutical Operations Provider
Genome Designs Partners with SciDM Group, Securing High Performance Bioinformatics Tools for Internal Pipelines and Custom Projects
Genome Designs, Inc., custom genome annotation and metabolic modeling service provider, today announced a partnership with SciDM Group, a bioinformatics tools developer. Genome Designs will be using SciDM Group’s high performance database engine, transcriptomics data processing pipeline, and... - April 27, 2012 - Genome Designs
Foamix Obtains US Patent "Waterless Hydrophilic Foam" for Dermatological and Gynecological Drugs, Such as Antibiotics, Antifungals and Corticosteroids
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - April 27, 2012 - Foamix Ltd
Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York
They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.
Ameridose Sponsors Health Connect Partners 2012 Spring Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to be a sponsor of the Health Connect Partners Spring Hospital Pharmacy Conference for a second consecutive year. The conference will take place from May 7-9, 2012 at the Hyatt Regency in... - April 26, 2012 - Ameridose, LLC
Ver Beaute Launches Natural Herb to Reverse the Aging Process for Women of All Ages
Ver Beaute Pueraria Mirifica Restores Youthful Appearance of Women as It Alleviates the Early Signs of Aging and Eliminates Unpleasant Changes to the Body - April 26, 2012 - ver beaute
Bioo Scientific Introduces Optimized Directional RNA-Seq Kits with Innovative Bias Reducing Technology
Bioo Scientific’s patent pending NEXTflex™ Directional RNA-Seq Kits and Barcodes Primer Sets provide an easy, flexible and non-biased solution for generating directional libraries. - April 26, 2012 - Bioo Scientific
Bioo Scientific Launches Transduction Reagents for Targeted Delivery Into Neuronal and Myeloid Cells
Bioo Scientific’s proprietary MyeloAim™ and NeuroAim™ Transduction Reagents offer targeted delivery of RNAi agents into myeloid and neuronal cells. - April 26, 2012 - Bioo Scientific
HEEDS MDO Optimization with VI-Motorsport Simulation Produces Early Success for Triple Eight Racing Team
MG KX Momentum car wins during first weekend of British Touring Car Championship - April 26, 2012 - Red Cedar Technology
PURE ONE Omega-3 Formulated with Non-Hexane Extracted Algae Oil DHA
Source-Omega today announced their PURE ONE Omega-3 supplement is now made using only non-hexane extracted ingredients including the algae oil and the sunflower lecithin. PURE ONE's flagship debut features their finished premium bulk formulation of SOURCE OIL™, the only water extracted... - April 25, 2012 - Source-Omega
Ithos Teams with Delta Partners to Help Integrate Food Safety and Supplier Quality IT Systems Into Organizations
Effective implementation of supplier ingredient quality and traceability software can help food processors minimize liability and brand risk. Ithos, Inc. is teaming with Delta Partners, Inc., a management consulting firm with unique expertise in food safety and organizational change management, to give food and beverage manufacturing companies another resource to successfully integrate new quality processes into their organizational ecosystems. - April 25, 2012 - Ithos, Inc.
Fertility Preservation Network Sponsors Susan G. Komen Race for the Cure Events
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was a sponsor in recent Race for the Cure fundraising events to benefit the Susan G. Komen Foundation. - April 25, 2012 - ReproTech, LLC
Stevens Students Compete in 5th International Roboboat Competition
Unmanned vessel innovations help to advance next-generation naval vessels - April 25, 2012 - Stevens Institute of Technology
Colorado BioScience Association Seeks Region’s Top Start-up Companies for Venture Showcase Competition at BioWest 2012
Colorado BioScience Association (CBSA) is now accepting applications from emerging bioscience companies for the Venture Showcase Competition at BioWest 2012. The deadline for entry is Friday, May 11th. Venture Showcase sponsors include Dorsey & Whitney LLP, EKS&H - Ehrhardt Keefe Steiner & Hottman PC, and the Metro Denver Economic Development Corporation. - April 25, 2012 - Colorado BioScience Association
Ameridose Unveils Innovative First Quarter Sustainability Enhancements
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to share exciting sustainability news for the first quarter of 2012. Aiming for the ultimate in energy efficiency, Ameridose is currently in the process of installing a made-in-the-USA... - April 24, 2012 - Ameridose, LLC
Young Women Beat Heart Attack
What could have killed them truly has made them stronger. Three Chicago-area survivors of a rare cause of heart attack called spontaneous coronary artery dissection (SCAD) will host the first-ever gathering of SCAD survivors worldwide the weekend of May 4-6, 2012. - April 24, 2012 - SCAD Research Inc
Privacy Analytics Unveils Version 2.5 of Its Unique Integrated De-identification and Intelligent Data Masking Software
The developer of the only commercially available integrated de-identification and intelligent data masking solution for the secondary use of personal health information announces the release of PARAT 2.5 (Privacy Analytics Risk Assessment Tool). - April 23, 2012 - Privacy Analytics Inc.
ICRC-Weyer Launch New Social Media Pages
ICRC-Weyer GmbH, a contract research organization (CRO) based in Berlin, Germany, has launched new corporate pages on the world’s leading social networks, Facebook and Google Plus. The company intends to take a pioneering role within the clinical research community by interacting with a global audience and sharing insights with the next generation of clinical research professionals. - April 21, 2012 - ICRC-Weyer GmbH
Nomination Deadline Extended for the BioProcess International Technical Application of the Decade Award to June 30, 2012
The nominations deadline has been extended to June 30, 2012. The Awards reception and ceremony has been moved to Tuesday, October 9, 5-8pm, as part of the BioProcess International Conference and Exhibition in Providence, Rhode Island. - April 19, 2012 - BioProcess International
Stem Cell Agency Unveils Strategic Partnership Fund to Increase Investment and Engagement with Industry in Stem Cell Therapies for Patients
The state’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) is committing up to $30 million to a Strategic Partnership Awards Initiative to attract industry engagement and investment in CIRM-funded stem cell research. - April 19, 2012 - California Institute for Regenerative Medicine
AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa
AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group
BioPharm Systems to Present at Oracle's 7th Annual Health Sciences Innovation Forum
BioPharm Systems, a leading provider of clinical trial, data, and drug safety solutions, and a Gold level member of Oracle PartnerNetwork (OPN), today announced that Parambir Singh, vice president of clinical trial management solutions, and Dr. Rodney Lemery, vice president of safety and... - April 18, 2012 - BioPharm Systems
EinNel Technologies Will Distribute Red Cedar Technology Software in India
Red Cedar Technology announced today that EinNel Technologies has agreed to distribute the HEEDS family of design optimization software throughout India. Albert George of EinNel Technologies said, “Having surveyed the Indian market from the perspective of technology in use, we find that... - April 18, 2012 - Red Cedar Technology
Fertility Preservation Network Adds Pittsburgh Fertility Preservation Program
Program extends access to Testicular Tissue Cryopreservation, as well as additional Fertility Preservation options. - April 18, 2012 - ReproTech, LLC
TTC Data Shows India Experiencing Sustained Growth in Commercial Clinical Trial Activity
India, with the world's largest pool of clinically ill patients, has more than 500,000 English-speaking doctors, many trained in the United States or the United Kingdom. India has experienced sustained growth in commercial clinical trials, and will soon become the world's third largest... - April 15, 2012 - TTC LLC
Dr. Yong Shi Awarded Patent for Innovative Control of Piezoelectric Nanofibers
Emerging nanofiber technology establishes tiny, self-powering sensors and actuators with compelling commercial applications. - April 14, 2012 - Stevens Institute of Technology
G&G Vitamins Offering New Line of Multivitamins for Women
G&G Vitamins, one of the UK’s leading manufacturers of high quality vitamin and mineral products has announced that they are now releasing a new line of multivitamins for women. The company’s new products are designed to help women around the world to manage their dietary needs with... - April 14, 2012 - G&G Vitamins
TTC a Clinical Trial Organization Standard of Care™ Database Tracks 1.2 Billion Claims Annually
Web-Accessible Standard of Care™ Provides Objective Data on How Sites, Actually Treat Patients Within the Standard of Care - April 13, 2012 - TTC LLC
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
Dr. Simon Podkolzin’s International Green Chemistry Collaboration Wins NSF Grant
Nanoparticle catalysts for industrial chemical reactions use oxygen with only water as a byproduct. - April 12, 2012 - Stevens Institute of Technology
My Perfect Bones Adds Anti Stress Formula to Collection of Natural Organic Products
My Perfect Bones introduces the new Anti Stress Sports Formula to its all natural and organic line of supplements and remedies. The topical cream is used for anti-inflammatory joint and muscle pain relief by stimulating blood flow and accelerating the healing. - April 11, 2012 - My Perfect Bones
Hart Rank Associates Announces the Formation of Med-Pulse and Licensing Agreement with Florida Institute of Technology for Skin Cancer Laser Detection Patented Technology
Hart Rank Associates Announces the formation of Med-Pulse and Licensing Agreement with Florida Institute of Technology for Skin Cancer Laser Detection Patented Technology. The technology enables the development of a laser-based system to be used in doctor’s offices and specialty imaging centers to detect the presence of skin cancer cells in a patient. The in office laser-based system will reduce and/or replace painful, costly & time-consuming biopsies. - April 10, 2012 - Hart Rank Associates
CardioTabs Announces Promotion Partnership with Vitamin Angels
CardioTabs, along with their customers, are working to help Vitamin Angels reach 25 million children in 2012. - April 08, 2012 - CardioTabs
Flexeffect Presents Scientifically Proven Facial Exercises to Get Rid of Undereye Circles and Other Signs of Aging
FlexEffect Facialbuilding is promoting the Third Edition of its facial exercises program, which features techniques backed by new scientific research. - April 07, 2012 - Flex Effect - Facial Exercises
Higher Springtime UV Radiation Identified in Northern Europe
Based on a multi-year EU-funded study (EuroSun), the International Prevention Research Institute (iPRI) in Lyon, has concluded that UV radiation in Europe appears earlier in the year and farther north than originally believed. Data gathered between 1988 and 1992 demonstrates that in spring, parts... - April 06, 2012 - International Prevention Research Institute
ICRC-Weyer to Adjust Services Portfolio in Light of New European Health Claim Regulations
The German based contract research organization, ICRC-Weyer GmbH, has adjusted its services portfolio in order to meet new requirements for the European nutrition market. With the recent fundamental changes for health claims on dietary supplement product labels, manufacturers will have to invest in research and development. But only specialized CROs are able to manage the new challenge. - April 06, 2012 - ICRC-Weyer GmbH